Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4+ memory T cells in mice

Transplant Immunology

Volumn 22, Issue 3-4, 2010, Pages 128-136

  Liang, Hua ^a   Liao, Chongxian ^a   Qi, Zhongquan ^a   Sha, Chuang ^a   Xie, Baiyi ^a   Chen, Jibing ^a   Xia, Junjie ^a   Wang, Yongzhi ^a   Yao, Qing ^a   Zhao, Yongxiang ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

Accelerated rejection; Cardiac transplant model; Immunosuppressant; Memory T cells

Indexed keywords

ALLOANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; HERMES ANTIGEN; L SELECTIN; RAPAMYCIN; TACROLIMUS; TRANSFORMING GROWTH FACTOR BETA;

ADOPTIVE TRANSFER; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC GRAFT REJECTION; CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; DRUG EFFICACY; DRUG TREATMENT FAILURE; EFFECTOR CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MEMORY T LYMPHOCYTE; MIXED LYMPHOCYTE REACTION; MONOTHERAPY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURVIVAL TIME; T LYMPHOCYTE ACTIVATION;

ADOPTIVE TRANSFER; ANIMALS; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DISEASE PROGRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOLOGIC MEMORY; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; SIROLIMUS; T-LYMPHOCYTE SUBSETS; TACROLIMUS;

EID: 77951666756     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2009.09.003     Document Type: Article

References (27)

1. Bingaman A.W., Farber D.L. Memory T cells in transplantation: generation, function, and potential role in rejection. Am J Transplant 2004, 846-852.
2. McFarland R.D., Douek D.C., Koup R.A., Picker L.J. Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci USA 2000, 97:4215-4220.
3. Chou N.K., Chi N.H., Chen Y.S., Yu H.Y., Lee C.M., Huang S.C., et al. Heart retransplantation for heart allograft failure in Chinese heart transplant recipients: NTUH Experience. Transplant Proc 2006, 2147-2148.
4. Radovancevic B., McGifin D.C., Kobashigawa J.A. Re-transplantation in 7290 primary transplant patients: a 10-year multi-institutional study. J Heart Lung Transplant 2003, 862.
5. Minamimuraa K., Satoa K., Yagita H. Strategies to induce marked prolongation of secondary skin allograft survival in alloantigen-primed mice. Am J Transplant 2008, 761-772.
6. Burrows S.R., Silins S.L., Khanna R., Burrows J.M., Rischmueller M., McCluskey J., et al. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity. Eur J Immunol 1997, 27:1726-1736.
7. + regulatory T cells in part by expanding memory T cells in vivo. J Immunol 2008, 181:3193-3201.
8. Richard N., Mathew S., Michael L. Rapamycin in transplantation: a review of the evidence. Kidney Int 2001, 59:3-16.
9. Tobias S., Michael N. TOR, a central controller of cell growth. Cell 2000, 103:253-262.
10. Kahan B.D. Frontiers in immunosuppression. Transplant Proc 2008, 40:11-15.
11. Strauss L., Whiteside T.L., Knights A., Bergmann C., Knuth A., Zippelius A. Selective survival of naturally occurring human cd4+cd25+foxp3+ regulatory T cells cultured with rapamycin. J Immunol 2007, 178:320-329.
12. Korczak-Kowalska G., Wierzbicki P., Bocian K., et al. The influence of immunosuppressive therapy on the development of Cd4+cd25+ T cells after renal transplantation. Transplant Proc 2007, 39:2721-2723.
13. Kang J., Huddleston S.J., Fraser J.M., Khoruts A. De novo induction of antigen-specific cd4+cd25+foxp3+ regulatory T cells in vivo following systemic antigen administration accompanied by blockade of mTOR. J Leukoc Biol 2008, 83:1-10.
14. Koyama I., Nadazdin O., Boskovic S., Ochiai T., Smith R.N., Sykes M., et al. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am J Transplant 2007, 5:1055-1061.
15. Seder R.A., AR. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol 2003, 835-842.
16. Yang J., Brook M.O., Carvalho-Gaspa M. Allograft rejection mediated by memory T cells is resistant to regulation. Proc Natl Acad Sci USA 2007, 104:19954-19959.
17. Matsuura A., Abe T., Yasuura K. Simplified mouse cervical heart transplantation using a cuff technique. Transplantation 1991, 51:896-898.
18. Qi Z., Riesbeck K., Ostraat O., Tufveson G., Ekberg H. Single dose anti-CD4 monoclonal antibody for induction of tolerance to cardiac allograft in high- and low-responder rat strain combinations. Transpl Immunol 1997, 5:204-211.
19. Billingham M.E., Cary N.R., Hammond M.E., Kemnitz J., Marboe C., McCallister H.A., et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 1990, 9:587-593.
20. Winters G.L., Marboe C.C., Billingham M.E. The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant 1998, 17:754-760.
21. Gao W., Lu Y., Essawy B.E., Oukka M., Kuchroo V.K., Strom T.B. Contrasting effects of cyclosporine and rapamycin in de novo generation of alloantigen-specific regulatory T cells. Am J Transplant 2007, 1722-1732.
22. Chandok M.R., Farber D.L. Signaling control of memory T cell generation and function. Semin Immunol 2004, 285-293.
23. Wherry E.J., Teichgraber V., Becker T.C., Masopust D., Kaech S.M., Antia R., et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 2003, 4:225-234.
24. Weninger W., Crowley M.A., Manjunath N., von Andrian U.H. Migratory properties of naive, effector, and memory CD8(+) T cells. J Exp Med 2001, 194:953-966.
25. Oberbarnscheidt M.H., Ng Y.H., Chalasani G. The roles of CD8 central and effector memory T-cell subsets in allograft rejection. Am J Transplant 2008, 8:1809-1818.
26. Sugamura K., Ishii N., Weinberg A.D. Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40. Nature 2004, 420-431.
27. Koenen H., Michielsen E., Verstappen J., Fasse E., Joosten I. Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. Transplantation 2003, 75:1581-1590.